A placebo should be inert, but “vaccine” trials have their own special concept for what they consider to be a placebo.

Volunteer in AstraZeneca COVID-19 vaccine trial dies in Brazil: officials | New York Post | October 21, 2020

The Brazil National Health Surveillance Agency received a notification on October 19, 2020 that a volunteer had died.

According to a Brazilian news source, a 28-year-old doctor, Joao Pedro Feitosa, died after being given a “placebo.” (Vacina de Oxford: voluntário brasileiro morre, mas laboratório não informa se ele recebeu imunizante (original link: https://oglobo.globo.com/sociedade/vacina-de-oxford-voluntario-brasileiro-morre-mas-laboratorio-nao-informa-se-ele-recebeu-imunizante-24704301?utm_source=globo.com&utm_medium=oglobo) | O Globo Sociedade | October 21, 2020).

AstraZeneca decided there were no concerns about continuing the study.

Oxford University, which co-develops the vaccine, also decided there were no safety concerns.

They don’t release details directly on the volunteer or what happened.

So much for science.

More sources on this:

Brazil Confirms Death of Volunteer in COVID-19 Vaccine Trial | medscape.com | October 21, 2020

The research institute conducting the trials, Instituto D’Or de Ensino e Pesquisa (IDOR) claimed this is a “randomized, blind study” with half the volunteers receiving the “vaccine.”

Coronavirus vaccine volunteer in Brazil’s AstraZeneca trial dies — but authorities say trial to continue | CNN | October 21, 2020

“Vaccine experts note that volunteers in clinical trials can become ill or die for any number of reasons, and they may not be related to the vaccine.”

AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies | CNBC | October 21, 2020